Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new information regarding clinical trials for non-small cell lung cancer and head and neck squamous cell carcinoma, including the addition of new gene mutations and collaborators, while significant details about the trial's objectives and treatment protocols have been removed.
    Difference
    54%
    Check dated 2025-04-16T02:05:52.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.3%
    Check dated 2025-04-08T23:36:34.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T19:01:38.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:18:06.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now indicates that some NLM-NCBI services and products are experiencing heavy traffic, which may impact their performance and availability. Additionally, several dates related to updates and estimates have been modified or removed.
    Difference
    2%
    Check dated 2025-02-10T09:32:10.000Z thumbnail image

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.